via an increase in metabolic mass-specific activity-dependent metabolic rate and total energy expenditure (9) .
These phenotypic characteristics of the Kv1.3) ⁄ ) mice suggest that the olfactory system may participate in the regulation of metabolism. Several studies have reported that olfactory stimuli can modulate autonomic outflow and metabolism (10) (11) (12) (13) (14) . The effects of olfactory stimulation have a circadian component, whereby olfactory stimulation is effective only during the light phase, resulting in the modulation of basal metabolic rate only, as measured by changes in body temperature and intrascapular brown adipose tissue temperature (15) . Chronic olfactory stimulation, 15 min per day, 3 days a week for 6 weeks, results in a significant decrease in caloric intake and body weight with grapefruit oil (11) and, conversely, an increase in caloric intake and body weight with lavender oil stimulation (12) . Bilateral lesions of the main olfactory epithelium (which results in complete anosmia) or suprachiasmatic nucleus (SCN) (14) (15) (16) disrupt the autonomic responses to olfactory stimulation.
These observations lead to the hypothesis that the diet-induced up-regulation of basal metabolism of Kv1.3) ⁄ ) mice is a result of the increased sensitivity of the olfactory system of these 'Supersmeller' mice. To evaluate the importance of increasing the sensitivity of the olfactory bulb by decreasing Kv1.3 activity, bilateral olfactory bulbectomy (OBX) was used to make the 'Super-smeller' Kv1.3) ⁄ ) mice chronically anosmic. As a result, we have found that the resistance to weight gain and the up-regulation of basal metabolism in response to MHF-diet normally observed in Kv1.3) ⁄ ) mice is olfactory bulb dependent.
Materials and methods

Animal care and mouse lines
All mice were housed at the Florida State University vivarium in accordance with the institutional requirements for animal care. Kv1.3-null mice (Kv1.3) ⁄ )) were a generous gift from Drs Leonard Kaczmarek and Richard Flavell (Yale University, New Haven, CT, USA) and were generated by excision of the Kv1.3 promoter region and one-third of the 5¢ coding region in a C57BL6 ⁄ J background (17) . Male WT (C57BL6 ⁄ J; Kv1.3+ ⁄ +) and Kv1.3) ⁄ ) mice were maintained under a standard 12 ⁄ 12 h light ⁄ -dark cycle with ad lib. access to 5001 Purina Rodent chow (CF; 13.5% kcal fat; Purina Lab Diet Feed Mill, Richardson, VA) and water until 11 weeks of age, at which point, half were fed a MHF, 32% kcal fat, condensed milk diet from Research Diets (D12266B; New Brunswick, NJ, USA). Body weight and caloric intake were monitored biweekly.
OBX
Nine-week-old male mice were anaesthetised in accordance with National Institutes of Health (NIH) and Florida State University Animal Care and Use Committee procedures by an i.p. injection of 100 mg ⁄ kg ketamine and 8 mg ⁄ kg xylazine. A 1.5-cm midline incision was made between the eyes and then the scalp was deflected to expose the cranial covering of the olfactory bulbs. Two 1.5-mm holes (one over each olfactory bulb) were drilled through the skull, using a Dremel tool (Robert Bosch Tool Corp, Mount Prospect, IL, USA) with a sterile no. 106 bit to expose the underlying olfactory bulb tissue. Sham olfactory bulbectomy surgery ended at this point after closing the scalp incision with Vetbond Tissue Adhesive (3M Pet Care Products, Saint Paul, MN, USA). For OBX treatment, a sterile p10 Pipetman tip (Fisher Scientific, Fisher Scientific, Pittsburgh, PA, USA) connected to a suction hose and collection flask was used to aspirate the olfactory bulb tissue from the cavity. The cavity was then filled with sterile Gel Foam (UpJohn, Kalamazoo, MI, USA) as described previously (18) and the overlying scalp incision was closed using Vetbond Tissue Adhesive. Surgically-treated animals were allowed to recover for 2 weeks before placement on a dietary regime at 11 weeks of age. Animals were maintained on a control or MHF-diet for 26 weeks following recovery from surgery.
Behavioural and histological confirmation of olfactory bulbectomy
To evaluate the success of the OBX surgery, animals were subjected to a general anosmia test as described previously (3) by measuring the time taken to find a hidden chocolate-scented candy (Whopper; Publix Supermarkets, Tallahassee, FL, USA) and comparing it with the time taken to find a hidden, unscented marble. Each item was tested three times per subject. The resultant times were averaged within an animal per item and compared statistically with a Student's t-test. If the mean time taken to find the scented item was significantly lower than that of the unscented marble, indicating that the animal could smell, the subject was suspected to have an incomplete OBX and, after histological confirmation, was discarded from the study.
The behavioural results were confirmed by post mortem histological examination of the remaining olfactory bulb tissue or cavity. Post-fixed heads were decalcified in 0.3 M ethylenediaminetetraacetic acid for 3-5 days at 4°C. The decalcified heads were cryoprotected overnight in 10% sucrose in phosphate-buffered saline (PBS) followed by overnight incubation in 30% sucrose in PBS. Cryosections were prepared using a Cryostat Microtome model HM 500 OMV (Microm GmbH, Waldorf, Germany). Sixteen-micrometre thick horizontal sections were affixed to gelatin-coated slides, and stored at )20°C until use. The tissue sections were incubated in 0.1% Neutral Red for 15 min followed by four successive washes in distilled water, two 30-s washes in 100% ethanol and a 10-min xylene wash. The extent of olfactory bulb removal was visualised with a Nikon MicroPhot-FXA microscope (Nikon Inc., Mellville, NY, USA) and documented with a Fast 1394 Qucam digital camera (Qimaging, Surry, BC, Canada). If an OBX animal was not found to be anosmic or had more than 25% olfactory bulb tissue remaining, it was excluded from analysis. Using these two metrics, a total of four of 44 mice were excluded from the study.
Indirect calorimetry and behavioural monitoring
Oxygen consumption (VO 2 ; ml ⁄ min) and CO 2 production (VCO 2 ; ml ⁄ min) of individually housed mice were continuously monitored for 8 days at 23°C in custom-fabricated metabolic isolation chambers as previously described, 5-7 weeks after the beginning of diet treatment (9, 19, 20) . In brief, mice were placed in shoebox cages (26 · 47 · 13.5 cm) fitted with near-air tight lids that received fresh air at a rate of 0.5 l ⁄ min. Dry, mixed-cage air was sampled with a 250 ml ⁄ min flow rate and sent to O 2 and CO 2 gas analysers every 4 min for 30 s followed by VO 2 and VCO 2 determination by open-circuit respirometry in accordance with Bartholomew et al. (21) , with modifications to isolate successive samples (19) . All reported mean values were calculated for 12 h of dark and 11 h of light so that daily body weight, caloric intake and water consumption could be measured during the last hour of the light cycle. Because of technical restraints in the measurement and interpretation of open-circuit indirect calorimetry of small animals, we have reported both uncorrected (see Supporting information) and weight-corrected oxygen consumption in the light and dark phase and compared linear regressions of uncorrected oxygen consumption to weight by ANCOVA, as described previously (22) . Each cage was positioned on a custom-designed platform resting on a centred fulcrum with stiff strain-gauge load-beam transducers positioned under two adjacent corners to measure animal position and locomotor activity as described previously (9, 20) . Locomotor activity was reported in metres, binned every 30 s, and measured at a 1-mm resolution. Daily caloric intake was calculated by measurement of consumed powdered Purina 5001 rodent chow (3.3 kcal ⁄ g) or MHF rodent chow (4.41 kcal ⁄ g). Dark and light phase energy expenditure were calculated using the Weir equation (23): EE = (3.94 · VO 2 ) + (1.1 · VCO 2 ). Total energy expenditure (TEE) was calculated as the sum of both the dark-and light-phase EE. As with oxygen consumption, we have reported uncorrected and weight-corrected TEE and compared linear regressions of uncorrected TEE to weight with an ANCOVA (see Supporting information).
Fat pad and serum collection
After 26 weeks of control or MHF-diet treatment, mice were fasted overnight, measured from nose to anus, and then weighed. Mice were then anaesthetised with isofluorane inhalation followed by decapitation in accordance with NIH and Florida State University Animal Care and Use Committee approved methods. Fasting glucose, insulin and leptin levels in trunk blood were determined as described previously (9) . Briefly, an Ascensia Contour Blood Glucose Monitoring System (Bayer Healthcare, Mishawaka, IN, USA) was used immediately following decapitation to measure blood glucose. Serum was collected as described previously (9) and stored at )20°C for later examination with a Mouse Leptin ELISA Kit (Linco Research, St Charles, MO, USA) and an Ultrasensitive Mouse Insulin ELISA Enzyme Immunoassy (Mercodia AB, Uppsala, Sweden) to determine fasting serum levels of leptin and insulin, in accordance with the manufacturer's instructions. The skull was stripped of all external muscle and tissue and fixed in 4% formaldehyde in PBS at 4°C overnight for histological processing as described above. All visceral fat pads, including epididymal, retroperitoneal and mesenteric white adipose tissue (WAT), were removed from the abdominal cavity, separated, and weighed. Subcutaneous WAT was sub-sampled by weighing the fat pad on the right side of each animal, from the median line of the abdomen to the spine and the right hip to the first rib. Brown adipose tissue was removed from between the scapulae and weighed.
Statistical analysis
Metabolism, energy expenditure, locomotor activity, caloric intake and water consumption values were 2-day means after 5-6 days of acclimation of the animal to the metabolic chambers. Statistical significance was determined using either a Student's t-test or a two-way ANOVA across diet and surgery within a genotype using a Student-Newman-Keuls or Bonferroni post-hoc test, as indicated in text, at the 95% confidence interval. For both oxygen consumption and TEE, we have also compared linear regressions of uncorrected TEE and oxygen consumption to weight with an ANCOVA. These ANCOVA comparisons provide appropriate statistical comparisons across animals of significantly different weights in the absence of fat free mass measurements. For a difference in elevation, P < 0.05 was considered statistically significant.
Results
Kv1.3 gene-targeted deletion prevents diet-induced obesity
To confirm the extent to which Kv1.3) ⁄ ) mice are resistant to diet-induced obesity, mice were fed either a control diet (13.5% kcal fat; CF) or a moderately high-fat diet (32% kcal fat; MHF) starting at 11 weeks of age until 37 weeks of age. Kv1.3+ ⁄ + mice on the MHF-diet gained significant weight, beginning at week 8, continuing throughout treatment, whereas Kv1.3) ⁄ ) mice did not (Fig. 1A) . Kv1.3+ ⁄ + mice fed the MHF-diet had a significant increase in all fat pads examined, except brown fat (Fig. 1B) . Kv1.3) ⁄ ) mice exhibited only an increase in mesenteric and brown fat when challenged with the MHF-diet (Fig. 1B) . Fasting glucose levels were not changed in Kv1.3+ ⁄ + mice with MHF-diet treatment, whereas glucose levels dropped in Kv1.3) ⁄ ) mice in response to the MHF-diet (see Supporting information, Fig. S1 ). Fasting insulin levels were significantly higher in Kv1.3+ ⁄ + mice in response to a MHF-diet, whereas there was no change in Kv1.3) ⁄ ) mice (see Supporting information, Fig. S1 ). MHF-diet treatment caused a significant elevation of leptin in Kv1.3+ ⁄ + but not Kv1.3) ⁄ ) mice (see Supporting information, Fig. S1 ). 
Kv1.3) ⁄ ) mice are no longer resistant to diet-induced obesity following olfactory bulbectomy
To determine whether the resistance to diet-induced obesity observed in Kv1.3) ⁄ ) mice is a result of their increased olfactory sensitivity or something intrinsic to the olfactory bulb and its efferent projections, we performed sham or OBX surgeries at 9 weeks of age. After a 2-week recovery period, mice were fed either a CF-or MHF-diet for 26 weeks. OBX alone decreased body weight and epididymal adiposity in Kv1.3+ ⁄ + mice by 15 weeks of CF-diet treatment; however, OBX did not prevent or significantly reduce weight gain or adiposity during the MHF-diet treatment ( Fig. 2A,C) . In Kv1.3) ⁄ ) mice, OBX alone had the opposite effect in that body weight significantly increased by 10 weeks for CF-diet animals and epididymal and mesenteric adiposity was significantly increased by 26 weeks (Fig. 2B,D) . Furthermore, removal of the olfactory bulbs resulted in weight gain and increased adiposity of Kv1.3) ⁄ ) mice challenged with a MHFdiet (OBX MHF), completely reversing the effect of the Kv1.3 gene-targeted deletion on resistance to diet-induced weight gain (Fig. 2B,D) . Sham-operated Kv1.3) ⁄ ) mice maintained on a MHFdiet were not significantly different in weight and adiposity from OBX-operated mice maintained on a CF diet, although they were significantly higher than unoperated Kv1.3) ⁄ ) mice (Fig. 1) at the same time as being significantly lower than OBX-operated Kv1.3) ⁄ ) mice on the MHF-diet (Fig. 2) . This intermediate phenotype in the Kv1.3) ⁄ ) mice could be a result of differences in inflammatory responses to surgery or potential disruption of the blood-brain barrier.
At the end of the 26 weeks of diet treatment, there were no significant differences detected in Kv1.3) ⁄ ) mice for fasting glucose or insulin (see Supporting information, Fig. S2 ) compared to that observed for unoperated animals. In Kv1.3+ ⁄ + mice, glucose and leptin levels were elevated with MHF-diet with either surgical treatment, although insulin was only significantly elevated with a combination of both MHF and OBX treatment (see Supporting information, Fig. S2 ). Bulbectomy alone and in combination with MHF-challenge now caused a significant elevation of leptin in Kv1.3) ⁄ ) mice (see Supporting information, Fig. S2 ) compared to the MHF-challenged, unoperated mice.
Olfactory bulbectomy transiently increases caloric intake
Caloric intake was monitored throughout the 26 weeks of the feeding treatment as well as 1 week before the beginning of diet treatment and 1 week post-surgical treatment (Fig. 3) . Both Kv1.3+ ⁄ + and Kv1.3) ⁄ ) OBX mice had higher caloric intake in the week before diet treatment began, which persisted in CF but not MHF fed Kv1.3+ ⁄ + mice (Fig. 3, left panel) and both CF and MHF fed Kv1.3) ⁄ ) mice (Fig. 3, right panel) for the first 4 weeks of diet treatment. After the first 5 weeks of diet treatment, all mice had similar weekly caloric intake, regardless of caloric source. Lowercase letters indicate significant differences within + ⁄ + mice and uppercase letters indicate significant differences within ) ⁄ ) mice as determined by a two-way ANOVA (within a genotype for treatment versus time) at the 95% confidence interval, followed by a Bonferroni post-hoc test. (C, D) Lowercase letters indicate significant differences within + ⁄ + mice and uppercase letters indicate significant differences within ) ⁄ ) mice as determined by a one-way ANOVA (within a fat pad for a genotype) at the 95% confidence interval, followed by a Bonferroni post-hoc test. CF, control; MHF, moderately high-fat.
Olfactory bulbectomy prevents the MHF-diet induced increase in basal metabolic rate in Kv1.3) ⁄ ) mice
To examine the underlying metabolic and ⁄ or behavioural changes that contribute to the adiposity phenotypes, OBX mice were placed in custom-built metabolic chambers after 5-7 weeks of diet treatment (7-9 weeks post surgery). Dark and light phase oxygen consumption (VO 2 ) or metabolism, as well as locomotor activity, were monitored for 8 days (4 days of acclimation and 4 days of data collection). At the time of metabolic monitoring, the weight of animals across treatments was significantly different (Fig. 4A) and, by the end of the 26 weeks, the overall nose to anus lengths (Fig. 4B ) became significantly different. Taken together with the slight mismatch in adiposity and final body weight in the Kv1.3) ⁄ ) mice (Fig. 2) , these results suggest an overall change in growth and lean mass, necessitating some sort of normalisation. Because of the established effects of animal size on metabolism and energy expenditure (EE) and the caveats intrinsic to various approaches to normalise metabolism for body mass (22), we chose to report both metabolic mass-specific VO 2 (nVO 2 ; ml ⁄ min ⁄ kg of body weight 0.75 ; regression. The linear regression lines were then compared with an ANCOVA to detect changes in elevation, as suggested by Arch et al. (22) . These ANCOVA measurements, although imperfect when used with low sample number and small variability, corroborate the nVO 2 results. Olfactory bulbectomy alone does not result in significant changes in dark phase (basal plus activity-dependent) or light phase (basal) nVO 2 (Fig. 4C,D) , VO 2 (see Supporting information, Fig. S3A ,B) or locomotor activity (Fig. 5A,B) for either genotype. MHF-diet treatment selectively and significantly increased basal nVO 2 in Kv1.3) ⁄ ) mice but not Kv1.3+ ⁄ + mice (Fig. 4D ) without changing locomotor activity (Fig. 5B) . OBX prevented the MHF-diet-induced increase in basal nVO 2 (Fig. 4D) , as well as diet-induced decrease, in the activity-dependent nVO 2 (Fig. 4C ) in Kv1.3) ⁄ ) mice but not Kv1.3+ ⁄ + mice. These results were confirmed by ANCOVA of the linear regression relationships of MHF-diet treated sham and OBX mice for both Kv1.3+ ⁄ + (see Supporting information, Fig. S3C,D) and Kv1.3) ⁄ ) mice (see Supporting information, Fig. S3E,F) . These data show that there are no significant differences for the relationship of weight and VO 2 between sham and OBX treatment in MHF fed Kv1.3+ ⁄ + mice. However, OBX significantly reduces both the dark and light phase VO 2 in Kv1.3) ⁄ ) mice treated with a MHF-diet without significant changes in locomotor activity (Fig. 5A,B) .
The collective metabolic changes measured for the Kv1.3) ⁄ ) mice are attributed to significant changes in metabolic mass specific total energy expenditure (nTEE; kcal ⁄ kg of body weight 0.75 ; Fig. 6 ). MHF feeding of sham-operated Kv1.3) ⁄ ) mice resulted in a trend (p < 0.1) for increased nTEE and a significant increase in TEE compared to the CF-diet condition ( Fig. 6 ; see also Supporting information, Fig. S4A ). OBX treatment significantly decreased nTEE and TEE in Kv1.3) ⁄ ) mice challenged with a MHF-diet ( Fig. 6 ; see also Supporting information, Fig. S4A,C) .
Discussion
It has previously been shown that gene-targeted deletion of Kv1.3 reduces weight gain in a genetic model of obesity by selectively increasing activity-dependent metabolism (9), prevents diet-induced obesity by selectively increasing basal metabolic rate (8) and increases olfactory sensitivity (3). In the present study, we confirm that Kv1.3) ⁄ ) mice are resistant to diet-induced obesity as a result of a selective increase in basal metabolic rate. However, OBX, a procedure that results in chronic anosmia or large olfactory deficits, completely blocks the basal metabolic rate up-regulation that is normally observed in Kv1.3) ⁄ ) mice in response to a MHF-diet challenge. By preventing the up-regulation in basal metabolic rate and concomitant TEE, OBX Kv1.3) ⁄ ) mice now exhibit diet-induced obesity. Olfactory bulbectomy of rats and mice results in general odorant and semio-chemical anosmia, as a result of the obligatory removal of both the accessory and the main olfactory bulbs. It is also a model of depression resulting in associative-learning and memory deficits, stress-induced hyperactivity, decreased mobility in the forced swim test, reduced food-motivated behaviours, reduced sexual activity and differential changes in aggressive behaviours (25) . OBX can also result in energy-balance related changes such as weight loss (26, 27) , short-term increased caloric intake (27, 28) , locomotor activity (26) , heart rate and body temperature (29, 30) . There is also evidence in several rodent species and at least one primate species for the disruption of olfactory bulb-mediated circadian rhythms revealed by OBX surgery (28, (30) (31) (32) (33) (34) .
During the experiments reported in the presented study, no gross differences in overall behaviour were observed, with the exception of a more docile nature in OBX, MHF-diet treated mice of both genotypes. However, no systematic evaluation of depression-like behaviours was performed. Therefore, it is unknown whether OBX induces depression-like symptoms in Kv1.3) ⁄ ) mice or whether those symptoms would manifest differently in these mice. We did observe a decrease in body weight in Kv1.3+ ⁄ + mice fed a control fat diet (CF) as a result of OBX treatment similar to that found previously (26) . A stress-induced increase in locomotor activity attributed to OBX as reported previously (26, 35, 36) was not observed in the present study. This could have been because the mice were allowed to acclimate to the metabolic chambers for at least 4 days before data were used for baseline analysis, although OBX-treated Kv1.3) ⁄ ) mice did tend to be hyperactive in the absence of a MHF-diet. Caloric intake was transiently increased within the first 4-7 weeks post OBX in both genotypes regardless of caloric source. It is also interesting that CF-treated Kv1.3) ⁄ ) mice gained weight as a result of OBX treatment, whereas Kv1.3+ ⁄ + mice lost weight under the same conditions. The olfactory system, including the olfactory bulb, is now being considered not simply as a detector of external chemical cues but of internal metabolic chemical cues such as insulin, glucose and leptin (4, (37) (38) (39) . Therefore, regardless of any depressive nature of OBX surgery in rodents, the changes observed with OBX are attributable to the removal of intrinsic olfactory bulb mechanisms or perturbation of the bulb's input to downstream targets.
The olfactory bulb projects to many brain regions, either directly or indirectly, that are responsible for regulation of sympathetic and parasympathetic tone, and therefore it has the opportunity to regulate energy balance. The OB projects directly to the piriform cortex, amygdala, entorhinal cortex, anterior olfactory nucleus and the taenia tecta (40) . The piriform cortex, amygdala, entorhinal cortex and anterior olfactory nucleus send projections to the dorsal endopiriform nucleus which in turn projects to the SCN of the hypothalamus (40) . The taenia tecta projects directly to the SCN (40) . The SCN is the internal clock that dictates many physiological, behavioural and endocrine rhythms of the body (41, 42) . Heart rate, blood pressure, metabolism, leptin, insulin and glucose regulation all have a circadian component that is controlled by the SCN via multisynaptic connections from the SCN to the paraventricular nucleus of the hypothalamus, and then through either the intermediolateral column of the spinal cord to regulate sympathetic tone, or the dorsal motor nucleus of the vagus to regulate parasympathetic activity (43) .
A series of studies reported that odour stimulation can differentially modulate sympathetic and parasympathetic activity to modulate rodent heart rate, blood pressure, lypolysis, caloric intake, body weight, plasma glycerol and body temperature in an odour-specific manner (11-13, 15, 16, 44) as determined by ZnSO 4 lesioning and xylocane inactivation of the olfactory epithelium. Olfactory-dependent modulation of these parametres is only effective during the light phase of the circadian cycle and is completely abolished by SCN lesion (15) . 'Super-smeller' Kv1.3) ⁄ ) mice have an increase in basal metabolic rate in response to the MHF-diet that is prevented in the anosmic, OBX condition. OBX-treated Kv1.3+ ⁄ + mice exhibit no change in either basal or activity-dependent metabolic rate. The olfactory bulb dependent up-regulation of basal metabolism of the Kv1.3) ⁄ ) mice in response to the MHF is similar to that reported by Tanida et al. (15) . Specifically, acute stimulation with grapefruit oil results in increased basal metabolism, and not activity-dependent or dark phase metabolism, as measured by core body and intrascapular brown fat temperature (15) and decreased body weight with chronic olfactory stimulation. Although ZnSO 4 lesioning and xylocane inactivation of the olfactory epithelium would have been good additions to the present study in theory, these manipulations are temporary and not conducive to its chronic design. More permanent olfactory epithelium ablation experiments are necessary to definitively differentiate between olfactory and olfactory bulb specific mechanisms and are planned for future studies.
Although our surgical and genetic manipulations represent artificial situations, there are many natural modulators of Kv1.3 activity in the olfactory bulb that may also affect the sensitivity of the olfactory system and thereby modulate sympathetic and parasympathetic output via the SCN, perhaps on a smaller scale. A naturally occurring polymorphism in the promoter region of the Kv1.3 gene in humans, associated with a gain of function, has been correlated with olfactory deficits, insulin insensitivity and impaired glucose tolerance in humans (7, 45) . Brain-derived neurotrophic factor and insulin, via activation of their respective tyrosine kinase receptors, suppress Kv1.3 current by tyrosine-specific phosphorylation in the olfactory bulb (1, [46] [47] [48] [49] [50] [51] . The cellular tyrosine kinase, Src, as well as the adapter proteins Grb10, PSD-95 and Shc, also modulate Kv1.3 current and are highly expressed in the olfactory bulb (51) (52) (53) . In making these mice 'Super-smellers' through dampening or eliminating Kv1.3 conductance, it is possible that we have increased the innate ability of the olfactory system to modulate sympathetic and parasympathetic output via the SCN. Additional studies are needed, in which the metabolic rate is monitored in Kv1.3+ ⁄ + versus Kv1.3) ⁄ ) mice in response to various olfactory stimuli and in the total absence of olfactory input (such as naris occlusion), to enable an understanding of the fine-tuned role of the olfactory system in energy balance.
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